The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Opioids Drug Market Research Report 2024
Synopsis
The Opioids Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioids Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioids Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Segment by Application
Pain Relief
Anesthesia
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioids Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Opioids Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioids Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioids Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Segment by Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Segment by Application
Pain Relief
Anesthesia
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioids Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Opioids Drug Market Overview
1.1 Product Overview and Scope of Opioids Drug
1.2 Opioids Drug Segment by Type
1.2.1 Global Opioids Drug Market Value Comparison by Type (2024-2030)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Opioids Drug Segment by Application
1.3.1 Global Opioids Drug Market Value by Application: (2024-2030)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Global Opioids Drug Market Size Estimates and Forecasts
1.4.1 Global Opioids Drug Revenue 2019-2030
1.4.2 Global Opioids Drug Sales 2019-2030
1.4.3 Global Opioids Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Opioids Drug Market Competition by Manufacturers
2.1 Global Opioids Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Opioids Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Opioids Drug Average Price by Manufacturers (2019-2024)
2.4 Global Opioids Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Opioids Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioids Drug, Product Type & Application
2.7 Opioids Drug Market Competitive Situation and Trends
2.7.1 Opioids Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Opioids Drug Players Market Share by Revenue
2.7.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioids Drug Retrospective Market Scenario by Region
3.1 Global Opioids Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Opioids Drug Global Opioids Drug Sales by Region: 2019-2030
3.2.1 Global Opioids Drug Sales by Region: 2019-2024
3.2.2 Global Opioids Drug Sales by Region: 2025-2030
3.3 Global Opioids Drug Global Opioids Drug Revenue by Region: 2019-2030
3.3.1 Global Opioids Drug Revenue by Region: 2019-2024
3.3.2 Global Opioids Drug Revenue by Region: 2025-2030
3.4 North America Opioids Drug Market Facts & Figures by Country
3.4.1 North America Opioids Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Opioids Drug Sales by Country (2019-2030)
3.4.3 North America Opioids Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Opioids Drug Market Facts & Figures by Country
3.5.1 Europe Opioids Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Opioids Drug Sales by Country (2019-2030)
3.5.3 Europe Opioids Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Opioids Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Opioids Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Opioids Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Opioids Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Opioids Drug Market Facts & Figures by Country
3.7.1 Latin America Opioids Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Opioids Drug Sales by Country (2019-2030)
3.7.3 Latin America Opioids Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioids Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioids Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Opioids Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Opioids Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Opioids Drug Sales by Type (2019-2030)
4.1.1 Global Opioids Drug Sales by Type (2019-2024)
4.1.2 Global Opioids Drug Sales by Type (2025-2030)
4.1.3 Global Opioids Drug Sales Market Share by Type (2019-2030)
4.2 Global Opioids Drug Revenue by Type (2019-2030)
4.2.1 Global Opioids Drug Revenue by Type (2019-2024)
4.2.2 Global Opioids Drug Revenue by Type (2025-2030)
4.2.3 Global Opioids Drug Revenue Market Share by Type (2019-2030)
4.3 Global Opioids Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Opioids Drug Sales by Application (2019-2030)
5.1.1 Global Opioids Drug Sales by Application (2019-2024)
5.1.2 Global Opioids Drug Sales by Application (2025-2030)
5.1.3 Global Opioids Drug Sales Market Share by Application (2019-2030)
5.2 Global Opioids Drug Revenue by Application (2019-2030)
5.2.1 Global Opioids Drug Revenue by Application (2019-2024)
5.2.2 Global Opioids Drug Revenue by Application (2025-2030)
5.2.3 Global Opioids Drug Revenue Market Share by Application (2019-2030)
5.3 Global Opioids Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Opioids Drug Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Description and Business Overview
6.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Purdue Pharma Opioids Drug Product Portfolio
6.2.5 Purdue Pharma Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mallinckrodt Opioids Drug Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Description and Business Overview
6.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amneal Pharma Opioids Drug Product Portfolio
6.4.5 Amneal Pharma Recent Developments/Updates
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Description and Business Overview
6.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Collegium Opioids Drug Product Portfolio
6.5.5 Collegium Recent Developments/Updates
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Description and Business Overview
6.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 J&J Opioids Drug Product Portfolio
6.6.5 J&J Recent Developments/Updates
6.7 Endo
6.6.1 Endo Corporation Information
6.6.2 Endo Description and Business Overview
6.6.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Endo Opioids Drug Product Portfolio
6.7.5 Endo Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Opioids Drug Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Description and Business Overview
6.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 INSYS Opioids Drug Product Portfolio
6.9.5 INSYS Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mylan Opioids Drug Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Opioids Drug Description and Business Overview
6.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hikma Opioids Drug Product Portfolio
6.11.5 Hikma Recent Developments/Updates
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Opioids Drug Description and Business Overview
6.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Egalet Opioids Drug Product Portfolio
6.12.5 Egalet Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioids Drug Industry Chain Analysis
7.2 Opioids Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioids Drug Production Mode & Process
7.4 Opioids Drug Sales and Marketing
7.4.1 Opioids Drug Sales Channels
7.4.2 Opioids Drug Distributors
7.5 Opioids Drug Customers
8 Opioids Drug Market Dynamics
8.1 Opioids Drug Industry Trends
8.2 Opioids Drug Market Drivers
8.3 Opioids Drug Market Challenges
8.4 Opioids Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
